EZH2 and breast cancer: Various reports have discovered that knockdown of EZH2 induces a mesenchymal to epithelial phenotypic reprogramming and blocks invasion in BC and the unexpected effect of EZH2 in inducing the MAPK signaling pathway was covered, an important regulator of BC invasion and metastasis [26–28].